Nanoparticles‐assisted delivery of antiviral‐siRNA as inhalable treatment for human respiratory viruses: A candidate approach against SARS‐COV‐2

The current pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has challenged healthcare structures across the globe. Although a few therapies are approved by FDA, the search for better treatment options is continuously on rise. Cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Ata, Qazi, Javaria, Rahman, Lutfur, Kanaras, Antonios G., Khan, Waheed S., Hussain, Irshad, Rehman, Asma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675679/
https://www.ncbi.nlm.nih.gov/pubmed/34485978
http://dx.doi.org/10.1002/nano.202000125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675679/
https://www.ncbi.nlm.nih.gov/pubmed/34485978
http://dx.doi.org/10.1002/nano.202000125

Ejemplares similares